ATE432942T1 - Löslicher heterodimerer cytokinrezeptor - Google Patents
Löslicher heterodimerer cytokinrezeptorInfo
- Publication number
- ATE432942T1 ATE432942T1 AT02713823T AT02713823T ATE432942T1 AT E432942 T1 ATE432942 T1 AT E432942T1 AT 02713823 T AT02713823 T AT 02713823T AT 02713823 T AT02713823 T AT 02713823T AT E432942 T1 ATE432942 T1 AT E432942T1
- Authority
- AT
- Austria
- Prior art keywords
- cytokine receptor
- heterodimeric cytokine
- soluble heterodimeric
- immunoglobulin
- subunit
- Prior art date
Links
- 102000003675 cytokine receptors Human genes 0.000 title 1
- 108010057085 cytokine receptors Proteins 0.000 title 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract 2
- 102000018358 immunoglobulin Human genes 0.000 abstract 2
- 101001044895 Homo sapiens Interleukin-20 receptor subunit beta Proteins 0.000 abstract 1
- 102100022705 Interleukin-20 receptor subunit beta Human genes 0.000 abstract 1
- 108010027445 interleukin-22 receptor Proteins 0.000 abstract 1
- 102000009548 interleukin-22 receptor activity proteins Human genes 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Genetics & Genomics (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27456001P | 2001-03-09 | 2001-03-09 | |
| US29986501P | 2001-06-21 | 2001-06-21 | |
| PCT/US2002/007214 WO2002072607A2 (en) | 2001-03-09 | 2002-03-07 | Soluble heterodimeric cytokine receptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE432942T1 true ATE432942T1 (de) | 2009-06-15 |
Family
ID=26956904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02713823T ATE432942T1 (de) | 2001-03-09 | 2002-03-07 | Löslicher heterodimerer cytokinrezeptor |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1399472B1 (de) |
| JP (1) | JP4009535B2 (de) |
| AT (1) | ATE432942T1 (de) |
| AU (1) | AU2002245652A1 (de) |
| CA (1) | CA2440596C (de) |
| DE (1) | DE60232511D1 (de) |
| DK (1) | DK1399472T3 (de) |
| EA (1) | EA005496B1 (de) |
| ES (1) | ES2327821T3 (de) |
| IL (2) | IL157726A0 (de) |
| WO (1) | WO2002072607A2 (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1234035B1 (de) | 1999-12-03 | 2010-02-24 | ZymoGenetics, Inc. | Menschliches zytokinrezeptor |
| US7122632B2 (en) | 1999-12-23 | 2006-10-17 | Zymogenetics, Inc. | Soluble Interleukin-20 receptor |
| US6610286B2 (en) | 1999-12-23 | 2003-08-26 | Zymogenetics, Inc. | Method for treating inflammation using soluble receptors to interleukin-20 |
| US20030170823A1 (en) | 1999-12-23 | 2003-09-11 | Presnell Scott R. | Novel cytokine ZCYTO18 |
| US20030023033A1 (en) * | 2001-07-26 | 2003-01-30 | Laure Dumoutier | Novel class II cytokine receptors and uses thereof |
| EP2177616B1 (de) | 2000-08-08 | 2012-02-29 | ZymoGenetics, Inc. | Lösliche Zcyctor 11 Cytokinrezeptoren |
| WO2002022153A2 (en) | 2000-09-15 | 2002-03-21 | Zymogenetics, Inc. | Use of a polypeptide comprising the extracellular domains of il-20rb for the treatment of inflammation |
| CA2439961A1 (en) | 2001-03-27 | 2002-10-03 | Zymogenetics, Inc. | Human cytokine receptor |
| AU2012216499B2 (en) * | 2001-10-19 | 2015-05-28 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| CA2463003A1 (en) | 2001-10-19 | 2003-04-24 | Zymogenetics, Inc. | Dimerized growth factor and materials and methods for producing it |
| AU2002357283B2 (en) | 2001-12-17 | 2007-08-16 | Zymogenetics, Inc. | Method for treating cervical cancer |
| EP1483298A4 (de) | 2002-02-11 | 2007-03-14 | Zymogenetics Inc | Materialien und verfahren zur herstellung dimerer wachstumsfaktoren |
| US7265211B2 (en) | 2002-03-22 | 2007-09-04 | Zymogenetics, Inc. | Anti-IL-TIF antibodies and methods of making |
| AU2004223837C1 (en) * | 2003-03-24 | 2012-03-15 | Zymogenetics, Inc. | Anti-IL-22RA antibodies and binding partners and methods of using in inflammation |
| EP1653995A1 (de) | 2003-08-08 | 2006-05-10 | Novo Nordisk A/S | Interleukin-20 zur behandlung und diagnose von mit neovaskularization verbunden zuständen |
| WO2005052000A2 (en) | 2003-11-21 | 2005-06-09 | Zymogenetics, Inc. | Anti-il-20 antibodies and binding partners and methods of using in inflammation |
| BRPI0516975A (pt) | 2004-10-22 | 2008-09-30 | Zymogenetics Inc | anticorpo ou seu fragmento de ligação a antìgeno, composição farmacêutica, imunoconjugado, hibridoma, anticorpo monoclonal, e, uso de um anticorpo ou seu fragmento de ligação a antìgeno |
| WO2006086396A2 (en) | 2005-02-08 | 2006-08-17 | Zymogenetics, Inc. | Anti-il-20, anti-il-22 and anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| ES2609429T3 (es) | 2005-05-12 | 2017-04-20 | Zymogenetics, Inc. | Composiciones y métodos para modular respuestas inmunitarias |
| CN107496917B (zh) | 2010-02-26 | 2021-06-11 | 诺沃—诺迪斯克有限公司 | 包含稳定抗体的组合物 |
| MX2012013586A (es) | 2010-05-28 | 2013-01-24 | Novo Nordisk As | Composiciones multi-dosis estables que comprenden un anticuerpo y un conservante. |
| JP6449338B2 (ja) | 2014-06-06 | 2019-01-09 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | グルココルチコイド誘導腫瘍壊死因子受容体（ｇｉｔｒ）に対する抗体およびその使用 |
| JP6812364B2 (ja) | 2015-06-03 | 2021-01-13 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | 癌診断用抗ｇｉｔｒ抗体 |
| GB201514875D0 (en) * | 2015-08-20 | 2015-10-07 | Autolus Ltd | Receptor |
| CN108738324B (zh) | 2015-11-19 | 2022-06-21 | 百时美施贵宝公司 | 抗糖皮质激素诱导的肿瘤坏死因子受体(gitr)抗体及其用途 |
| KR20200006115A (ko) | 2017-05-16 | 2020-01-17 | 브리스톨-마이어스 스큅 컴퍼니 | 항-gitr 효능제 항체에 의한 암의 치료 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965704A (en) * | 1997-08-05 | 1999-10-12 | Zymogenetics, Inc. | Class two cytokine receptor-11 |
| EP1141008A1 (de) * | 1998-12-31 | 2001-10-10 | Millennium Pharmaceuticals, Inc. | Cytokinin klasse ii rezeptor-ähnliche proteine und für diese kodierende nukleinsäuren |
-
2002
- 2002-03-07 AT AT02713823T patent/ATE432942T1/de active
- 2002-03-07 DK DK02713823T patent/DK1399472T3/da active
- 2002-03-07 IL IL15772602A patent/IL157726A0/xx not_active IP Right Cessation
- 2002-03-07 CA CA2440596A patent/CA2440596C/en not_active Expired - Fee Related
- 2002-03-07 DE DE60232511T patent/DE60232511D1/de not_active Expired - Lifetime
- 2002-03-07 AU AU2002245652A patent/AU2002245652A1/en not_active Abandoned
- 2002-03-07 ES ES02713823T patent/ES2327821T3/es not_active Expired - Lifetime
- 2002-03-07 EA EA200300983A patent/EA005496B1/ru not_active IP Right Cessation
- 2002-03-07 WO PCT/US2002/007214 patent/WO2002072607A2/en not_active Ceased
- 2002-03-07 EP EP02713823A patent/EP1399472B1/de not_active Expired - Lifetime
- 2002-03-07 JP JP2002571520A patent/JP4009535B2/ja not_active Expired - Fee Related
-
2010
- 2010-03-04 IL IL204299A patent/IL204299A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2440596C (en) | 2011-05-24 |
| JP4009535B2 (ja) | 2007-11-14 |
| ES2327821T3 (es) | 2009-11-04 |
| AU2002245652A1 (en) | 2002-09-24 |
| EP1399472B1 (de) | 2009-06-03 |
| WO2002072607A2 (en) | 2002-09-19 |
| WO2002072607A3 (en) | 2004-01-15 |
| JP2004536040A (ja) | 2004-12-02 |
| EP1399472A4 (de) | 2004-06-30 |
| IL204299A (en) | 2011-06-30 |
| EA200300983A1 (ru) | 2004-06-24 |
| DE60232511D1 (de) | 2009-07-16 |
| IL157726A0 (en) | 2004-03-28 |
| DK1399472T3 (da) | 2009-10-05 |
| EA005496B1 (ru) | 2005-02-24 |
| CA2440596A1 (en) | 2002-09-19 |
| EP1399472A2 (de) | 2004-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE432942T1 (de) | Löslicher heterodimerer cytokinrezeptor | |
| ATE407950T1 (de) | Löslicher interleukin-20 rezeptor | |
| EA200500330A1 (ru) | Антагонисты nogo рецепторов | |
| EP1572967A4 (de) | Auf il-1-rezeptor beruhende antagonisten sowie herstellungs- und verwendungsverfahren | |
| TW200732350A (en) | Methods for generating monovalent IgG | |
| ATE374042T1 (de) | Fc-fusionsproteine zur erhöhung der immunogenität von protein- und peptid-antigenen | |
| ATE490969T1 (de) | Modifizierte transferrin-fusionsproteine | |
| IS5217A (is) | Bræðsluprótín á föstu svæði úr beta-breytivaxtarþætti (TGF-beta) af gerð II og ónæmisglóbúlíni | |
| DK1140173T3 (da) | Vaskulære endothelcellevækstfaktorantagonister og anvendelser deraf | |
| IL226637A0 (en) | An isolated heterodimeric cytokine receptor | |
| DE60333306D1 (de) | Modifizierte transferrin-fusionsproteine mit doppelten transferrin-amino- oder carboxy-terminalen domänen | |
| DK1691833T3 (da) | Præparater der omfatter polypeptider | |
| ATE542545T1 (de) | Taci-immunoglobulin-fusionsproteine | |
| WO2003004529A3 (en) | Ephrin-tie receptor materials and methods | |
| DE602004022390D1 (de) | Verbesserte fc-fusionsproteine | |
| TW200512947A (en) | Optical module, optical transceiver, and optical joint sleeve | |
| EA200400384A1 (ru) | Растворимый рецептор т-клетки |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1399472 Country of ref document: EP |